New startup Haemanthus raises concerns similar to Theranos, focusing on blood-testing amidst fears of ethical implications linked to Elizabeth Holmes.
Billy Evans launches Haemanthus despite Holmes's legal restrictions, with ambitions of major funding and future testing devices.